Technology and Strategy Roundtables will run from 12:00-12:45 with 15 minutes for a quick summary from each table at the front of the room. These will take place in the conference rooms: look for your table number to participate.
1. Raw material supply for the commercial manufacturing of cell and gene therapies
In Pursuit of the First Clinical Trial for a Chinese iPSc Derived ATMP (iPSc-Endothelial Progenitor Cell) in the UK
Manufacturing protocols and QC standards for iPSc-EPC have been developed in Allife Medicine.
Pre-clinical studies have shown positive effects on neuron re-myelination in rats and that iPSc-EPC is able to trigger endothelium lesion recovery in nude mice, with little safety concern in Toxicity and Tumorigenesis.
A Phase I/IIα clinical trial to use autologous iPSc-EPC for Ischemic Stroke is planned to start in early 2021.